The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

those prescribed semaglutide to treat type 2 diabetes – as it was originally intended – are now facing supply issues due to a surge in “off-label” prescriptions for weight loss.